HRT Financial’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.02M | Buy |
330,661
+180,342
| +120% | +$1.64M | 0.01% | 601 |
|
|
2025
Q1 | $1.2M | Sell |
150,319
-508
| -0.3% | -$4.04K | 0.01% | 896 |
|
|
2024
Q4 | $818K | Sell |
150,827
-21,224
| -12% | -$115K | ﹤0.01% | 1029 |
|
|
2024
Q3 | $1.24M | Buy |
172,051
+52,719
| +44% | +$381K | 0.01% | 1046 |
|
|
2024
Q2 | $1.3M | Buy |
+119,332
| New | +$1.3M | 0.01% | 838 |
|
|
2024
Q1 | – | Sell |
-66,244
| Closed | -$1.44M | – | 2813 |
|
|
2023
Q4 | $1.44M | Buy |
+66,244
| New | +$1.44M | 0.01% | 762 |
|
|
2023
Q3 | – | Sell |
-16,892
| Closed | -$794K | – | 2745 |
|
|
2023
Q2 | $794K | Sell |
16,892
-20,180
| -54% | -$949K | 0.01% | 1005 |
|
|
2023
Q1 | $1.56M | Buy |
37,072
+16,522
| +80% | +$693K | 0.02% | 689 |
|
|
2022
Q4 | $783K | Buy |
20,550
+6,885
| +50% | +$262K | 0.01% | 1038 |
|
|
2022
Q3 | $535K | Buy |
+13,665
| New | +$535K | 0.01% | 1312 |
|
|
2022
Q2 | – | Sell |
-19,319
| Closed | -$639K | – | 3438 |
|
|
2022
Q1 | $639K | Sell |
19,319
-5,255
| -21% | -$174K | ﹤0.01% | 1306 |
|
|
2021
Q4 | $1.05M | Sell |
24,574
-772
| -3% | -$32.8K | 0.01% | 936 |
|
|
2021
Q3 | $1.12M | Buy |
+25,346
| New | +$1.12M | 0.01% | 1031 |
|
|
2021
Q2 | – | Sell |
-10,640
| Closed | -$796K | – | 3265 |
|
|
2021
Q1 | $796K | Buy |
10,640
+2,988
| +39% | +$224K | 0.01% | 1207 |
|
|
2020
Q4 | $661K | Sell |
7,652
-21,113
| -73% | -$1.82M | 0.01% | 828 |
|
|
2020
Q3 | $1.76M | Buy |
28,765
+13,262
| +86% | +$811K | 0.05% | 263 |
|
|
2020
Q2 | $644K | Buy |
+15,503
| New | +$644K | 0.02% | 608 |
|
|
2019
Q4 | – | Sell |
-2,228
| Closed | -$312K | – | 1486 |
|
|
2019
Q3 | $312K | Buy |
+2,228
| New | +$312K | 0.01% | 814 |
|
|
2018
Q3 | – | Sell |
-3,200
| Closed | -$500K | – | 437 |
|
|
2018
Q2 | $500K | Buy |
+3,200
| New | +$500K | 0.18% | 92 |
|